Association of Antipsychotic Treatment With Risk of Unexpected Death Among Children and Youths
暂无分享,去创建一个
K. Murray | W. Ray | C. Stein | W. Cooper | K. Hall | J. Daugherty | S. Patrick | D. Fuchs | J. Daugherty
[1] M. De Hert,et al. The Urgent Need for Optimal Monitoring of Metabolic Adverse Effects in Children and Youngsters Who Take On-label or Off-label Antipsychotic Medication. , 2018, JAMA psychiatry.
[2] J. Newcomer,et al. Metabolic Effects of Antipsychotics on Adiposity and Insulin Sensitivity in Youths: A Randomized Clinical Trial , 2018, JAMA psychiatry.
[3] M. R. Ghadami,et al. A weight-independent association between atypical antipsychotic medications and obstructive sleep apnea , 2018, Sleep and Breathing.
[4] N. Ghaziuddin,et al. Neuroleptic Malignant Syndrome/Malignant Catatonia in Child Psychiatry: Literature Review and a Case Series. , 2017, Journal of child and adolescent psychopharmacology.
[5] R. Kobau,et al. The Sudden Death in the Young Case Registry: Collaborating to Understand and Reduce Mortality , 2017, Pediatrics.
[6] K. Huybrechts,et al. Propensity Score Weighting Compared to Matching in a Study of Dabigatran and Warfarin , 2017, Drug Safety.
[7] Irina O Karpov,et al. Trends in Antipsychotic Prescribing in Medicaid-Eligible Youth. , 2016, Journal of the American Academy of Child and Adolescent Psychiatry.
[8] Matthew A. Silva,et al. Acute Pancreatitis Associated With Antipsychotic Medication: Evaluation of Clinical Features, Treatment, and Polypharmacy in a Series of Cases , 2016, Journal of clinical psychopharmacology.
[9] M. Onofrj,et al. Olanzapine-related repetitive focal seizures with lingual dystonia. , 2016, Epileptic disorders : international epilepsy journal with videotape.
[10] M. Olfson,et al. Type 2 Diabetes Mellitus in Youth Exposed to Antipsychotics: A Systematic Review and Meta-analysis. , 2016, JAMA psychiatry.
[11] J. Haukoos,et al. The Propensity Score. , 2015, JAMA.
[12] M. Olfson,et al. Treatment of Young People With Antipsychotic Medications in the United States. , 2015, JAMA psychiatry.
[13] C. Correll,et al. Antipsychotic Use in Youth Without Psychosis: A Double-edged Sword. , 2015, JAMA psychiatry.
[14] Jørgen K. Kanters,et al. The cardiac safety of aripiprazole treatment in patients at high risk for torsade: a systematic review with a meta-analytic approach , 2015, Psychopharmacology.
[15] A. Localio,et al. Risk for incident diabetes mellitus following initiation of second-generation antipsychotics among Medicaid-enrolled youths. , 2015, JAMA pediatrics.
[16] Yasushi Okuno,et al. Antipsychotics-Associated Serious Adverse Events in Children: An Analysis of the FAERS Database , 2015, International journal of medical sciences.
[17] W. Ray,et al. Performance of time‐dependent propensity scores: a pharmacoepidemiology case study , 2015, Pharmacoepidemiology and drug safety.
[18] M. Olfson,et al. Antipsychotics and the risk of type 2 diabetes mellitus in children and youth. , 2013, JAMA psychiatry.
[19] A. Wu,et al. Cardiotoxicity in a citalopram and olanzapine overdose. , 2013, The Journal of emergency medicine.
[20] D. Kolar,et al. [Chlorpromazine-induced status epilepticus: a case report]. , 2013, Srpski Arhiv za Celokupno Lekarstvo.
[21] Jaskaran Singh,et al. Risperidone Dosing in Children and Adolescents with Autistic Disorder: A Double-Blind, Placebo-Controlled Study , 2012, Journal of Autism and Developmental Disorders.
[22] P. Mehler,et al. Trends in Reporting Methadone-Associated Cardiac Arrhythmia, 1997–2011 , 2013, Annals of Internal Medicine.
[23] M. Gulisano,et al. Mandatory electrocardiographic monitoring in young patients treated with psychoactive drugs , 2013, European Child and Adolescent Psychiatry.
[24] V. Auwärter,et al. Accidental clozapine intoxication in a toddler: clinical and pharmacokinetic lessons learnt , 2013, Journal of clinical pharmacy and therapeutics.
[25] M. Olfson,et al. National trends in the office-based treatment of children, adolescents, and adults with antipsychotics. , 2012, Archives of general psychiatry.
[26] K. Murray,et al. ADHD drugs and serious cardiovascular events in children and young adults. , 2011, The New England journal of medicine.
[27] Paul G Shekelle,et al. Efficacy and comparative effectiveness of atypical antipsychotic medications for off-label uses in adults: a systematic review and meta-analysis. , 2011, JAMA.
[28] P. Austin. An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies , 2011, Multivariate behavioral research.
[29] F. Yagmur,et al. Acute respiratory distress due to antipsychotic drugs. , 2010, Pharmacopsychiatry.
[30] William R. Shadish,et al. A Primer on Propensity Score Analysis , 2010 .
[31] C Michael Stein,et al. Atypical antipsychotic drugs and the risk of sudden cardiac death. , 2009, The New England journal of medicine.
[32] S. Patten,et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. III. Pharmacotherapy. , 2009, Journal of affective disorders.
[33] Christopher Welsh,et al. Methadone-associated Q-T interval prolongation and torsades de pointes. , 2009, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
[34] G. O’Malley,et al. Pediatric ziprasidone overdose. , 2009, Pediatric emergency care.
[35] M. Norris,et al. QTc prolongation associated with atypical antipsychotic use in the treatment of adolescent-onset anorexia nervosa. , 2009, Journal of the Canadian Academy of Child and Adolescent Psychiatry = Journal de l'Academie canadienne de psychiatrie de l'enfant et de l'adolescent.
[36] R. Dhamija,et al. Diabetic Ketoacidosis Induced by Aripiprazole in a 12-Year-Old Boy , 2008, Diabetes Care.
[37] C. Schönfeldt-Lecuona,et al. Respiratory Dysfunction in Sleep Apnea Associated with Quetiapine , 2008, Pharmacopsychiatry.
[38] M. Bentley,et al. Inadvertent Administration of Intravenous Ziprasidone Leading to Bradycardia and QT Interval Prolongation , 2008, The Annals of pharmacotherapy.
[39] D. Jeste,et al. ACNP White Paper: Update on Use of Antipsychotic Drugs in Elderly Persons with Dementia , 2008, Neuropsychopharmacology.
[40] G. C. Alexander,et al. A qualitative exploration of depression in emerging adulthood: disorder, development, and social context. , 2007, General hospital psychiatry.
[41] C. Prakash,et al. Pancreatitis following Olanzapine Therapy: A Report of Three Cases , 2007, Case Reports in Gastroenterology.
[42] Andrew C Leon,et al. Expanding the black box - depression, antidepressants, and the risk of suicide. , 2007, The New England journal of medicine.
[43] S. Gosselin,et al. Amisulpride deliberate self‐poisoning causing severe cardiac toxicity including QT prolongation and torsades de pointes , 2006, The Medical journal of Australia.
[44] W. Ray,et al. Trends in prescribing of antipsychotic medications for US children. , 2006, Ambulatory pediatrics : the official journal of the Ambulatory Pediatric Association.
[45] Jennifer A. Kurth,et al. Pediatric case report of quetiapine overdose and QTc prolongation. , 2004, Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists.
[46] W. Ray,et al. New users of antipsychotic medications among children enrolled in TennCare. , 2004, Archives of pediatrics & adolescent medicine.
[47] M. J. Barker,et al. Acute oxcarbazepine and atomoxetine overdose with quetiapine. , 2004, Veterinary and human toxicology.
[48] R. Baldessarini,et al. Multiple versus single antipsychotic agents for hospitalized psychiatric patients: case-control study of risks versus benefits. , 2004, The American journal of psychiatry.
[49] J. Shelton. A New Era Begins: Full Text and Indexing in PubMed Central , 2004 .
[50] W. Ray,et al. Evaluating medication effects outside of clinical trials: new-user designs. , 2003, American journal of epidemiology.
[51] W. Ray,et al. Population-based studies of adverse drug effects. , 2003, The New England journal of medicine.
[52] D. Sleet,et al. CDC School Health Guidelines to Prevent Unintentional Injuries and Violence , 2003, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.
[53] C. Morris-Kukoski,et al. Cardiotoxicity Associated With Intentional Ziprasidone And Bupropion Overdose , 2003, Journal of toxicology. Clinical toxicology.
[54] W A Ray,et al. Antipsychotics and the risk of sudden cardiac death. , 2001, Archives of general psychiatry.
[55] K. Fletcher,et al. Neuroleptic-related dyskinesias in children and adolescents. , 2001, The Journal of clinical psychiatry.
[56] S. Stahl. Peptides and psychiatry, Part 1: How synthesis of neuropeptides differs from classical neurotransmitter synthesis. , 1999, The Journal of clinical psychiatry.
[57] D A Savitz,et al. Recall accuracy for prescription medications: self-report compared with database information. , 1995, American journal of epidemiology.
[58] R E Johnson,et al. Comparing Sources of Drug Data about the Elderly , 1991, Journal of the American Geriatrics Society.
[59] W. Ray,et al. Methodological issues in evaluating expanded Medicaid coverage for pregnant women. , 1990, American journal of epidemiology.
[60] W A Ray,et al. Use of Medicaid data for pharmacoepidemiology. , 1989, American journal of epidemiology.
[61] M. Smyer,et al. Validation of two methods of data collection of self-reported medicine use among the elderly. , 1988, The Gerontologist.
[62] C. Correll,et al. Corrected QT changes during antipsychotic treatment of children and adolescents: a systematic review and meta-analysis of clinical trials. , 2015, Journal of the American Academy of Child and Adolescent Psychiatry.
[63] F. Thabet,et al. Aripiprazole-induced seizure in a 3-year-old child: a case report and literature review. , 2013, Clinical neuropharmacology.
[64] Vital signs: Unintentional injury deaths among persons aged 0-19 years - United States, 2000-2009. , 2012, MMWR. Morbidity and mortality weekly report.
[65] C. Correll. Antipsychotic use in children and adolescents: minimizing adverse effects to maximize outcomes. , 2008, Journal of the American Academy of Child and Adolescent Psychiatry.
[66] Soo-Churl Cho,et al. Temperament and character among Korean children and adolescents with anxiety disorders , 2008, European Child & Adolescent Psychiatry.
[67] D. Cooke,et al. Olanzapine-induced diabetes in a seven-year-old boy. , 2004, Journal of child and adolescent psychopharmacology.
[68] M. C. Catalano,et al. Atypical antipsychotic overdose in the pediatric population. , 2001, Journal of child and adolescent psychopharmacology.
[69] C. McDougle,et al. Tolerability Profile of Atypical Antipsychotics in Children and Adolescents , 2001, Paediatric drugs.
[70] P. Gajwani,et al. QT interval prolongation associated with quetiapine (Seroquel) overdose. , 2000, Psychosomatics.
[71] C. McDougle,et al. Risperidone in the treatment of two very young children with autism. , 1999, Journal of child and adolescent psychopharmacology.
[72] D. V. Jeste,et al. Tardive dyskinesia. , 1993, Schizophrenia bulletin.